|
Exclusivity Start Date
|
Generic Name
|
Trade Name
|
Indication for Original Approvala
|
|
8/28/01
|
Topiramated
|
Topamax
|
As adjunctive therapy in patients 2 years and older with seizures associated with Lennox-Gastaut syndrome
|
|
11/20/01
|
Bosentan
|
Tracleer
|
Treatment of pulmonary arterial hypertension
|
|
1/18/02
|
Nitisinone
|
Orfadin
|
Adjunctive therapy to dietary restriction of tyrosine and phenylalanine in treatment of hereditary tyrosinemia type 1
|
|
7/17/02
|
Oxybate
|
Xyrem
|
Treatment of cataplexy associated with narcolepsy
|
|
10/8/02
|
Buprenorphine in combination with naloxone
|
Suboxone
|
Treatment of opioid dependence in patients 16 years of age or older
|
|
10/8/02
|
Buprenorphine hydrochlorided
|
Subutex
|
Treatment of opioid dependence in patients 16 years of age or older
|
|
11/22/02
|
Nitazoxanide
|
Alinia
|
Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia
|
|
3/25/03
|
Pegvisomantc
|
Somavert
|
Treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate
|
|
7/31/03
|
Miglustatd
|
Zavesca
|
Treatment of mild to moderate Type I Gaucher disease in adults for whom enzyme replacement therapy is not a therapeutic option
|
|
12/1/03
|
Somatropin (r-DNA)c,e
|
Zorbtive
|
Treatment of short bowel syndrome in patients receiving specialized nutritional support
|
|
3/8/04
|
Cinacalcetd
|
Sensipar
|
Treatment of hypercalcemia in patients with parathyroid carcinoma
|
|
4/20/04
|
Apomorphine HClc
|
Apokyn
|
For the acute, intermittent treatment of hypomobility, “off” episodes, associated with advanced Parkinson’s disease
|
|
5/17/04
|
Tinidazole
|
Tindamax
|
(1) Treatment of giardiasis caused by G. duodenalis (also termed G. lamblia). (2) Treatment of intestinal amebiasis and amebic liver abcess caused by E. histolytica.
|